Different types of treatment are available for patients with ovarian epithelial cancer.

When found in its early stages, ovarian epithelial cancer can often be cured.

Epithelial cancer, which develops in the cells on the surface of the ovary.

This is thought to be a promotional event that may prolong certain epithelial cancers.

A marked increase in mortality from lung, bladder, and other epithelial cancers has been described.

The following is a list of ovarian epithelial cancer histologic classifications.

The following stages are used for ovarian epithelial cancer:

Treatment of recurrentovarian epithelial cancer may include the following:

Ovarian epithelial cancer is one type of cancer that affects the ovary.

Epithelial cancers in the lung appear to develop in a predictable series of steps extending over years.

Such methods could allow effective detection of epithelial cancer with an imaging system that is safe, non-invasive, and painless.

RHBDF2 may also play a role in ovarian epithelial cancer.

It has become apparent that patients with hereditary retinoblastoma are also at risk of developing epithelial cancers late in adulthood.

Treatment options for patients with all stages of ovarian epithelial cancer have consisted of surgery followed by chemotherapy.

The outcome for epithelial cancers of the lung depends on how the cells look under a microscope and the stage of the cancer.

Cells infected with certain types of epithelial cancer exhibit increased PKC-α activity.

Recurrentovarian epithelial cancer is cancer that has recurred (come back) after it has been treated.

Epithelial cancer cells use oxidative mitochondrial metabolism to "fuel" tumor growth and metastasis.

For more information from the National Cancer Institute about ovarian epithelial cancer, see the following:

The lead reviewer for Ovarian Epithelial Cancer Treatment is:

In the 1980s, analysis of the specimen finally confirmed the tumor to be verrucous carcinoma, a low-grade epithelial cancer with a low potential for metastasis.

As with most epithelial cancers, physical irritation has been associated with increased risk of malignant transformation of the urothelium.

Ovarian epithelial cancer is a disease in which malignant (cancer) cells form in the tissue covering the ovary.

PPARγ is a steroid hormone receptor which inhibits cellular growth of several epithelial cancers.

The majority of epithelial cancers are only moderately radiosensitive, and require a significantly higher dose of radiation (60-70Gy) to achieve a radical cure.